Compounded estriol vaginal cream prepared per prescriber direction for localized hormone therapy support. Prescription required.
Estriol Vaginal Cream is compounded by HDRx according to individualized prescriber specifications, including strength and base selection. A valid prescription from a licensed healthcare provider is required.
Estriol (E3) is a form of estrogen commonly discussed in bioidentical hormone replacement therapy (BHRT) planning, particularly when localized hormone support is considered appropriate. Compounded vaginal formulations allow providers to tailor concentration and delivery based on individual patient needs.
To learn more about estriol’s role within BHRT discussions, explore our educational resources on bioidentical hormone replacement therapy (BHRT), estriol and its potential uses in BHRT compounding, and balancing hormones in menopause with BHRT ingredients.
For broader context on hormone considerations in both women and men, see our discussion on addressing hormonal imbalance in clinical care planning.
Compounded medications are not FDA-approved and are prepared to meet specific patient needs. Patients should consult their healthcare provider to determine whether this formulation is appropriate for their individual health goals.
